Literature DB >> 3531348

Effect of a bacterial extract on cellular and humoral immune responses in humans.

M Rosenthal.   

Abstract

A lyophilized extract from E. coli (OM-89) was studied for its immunomodulating properties and tolerance in humans. Its oral administration to healthy volunteers produced a selective increase in the active T-cell population without changes in other lymphocyte populations. A significant increase in the proliferative response to concanavalin A and phytohemagglutin was recorded, but not to pokeweed mitogen. No significant changes were observed in the serum levels of IgG, IgA and IgM. The clinical and biological tolerance of OM-89 was excellent, without any adverse side-effects or production of circulating immune complexes or of autoantibodies, while the in vitro investigation showed that it is not a mitogen. Thus in healthy subjects OM-89 seems to act mainly on the cell-mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3531348     DOI: 10.3109/08923978609026492

Source DB:  PubMed          Journal:  J Immunopharmacol        ISSN: 0163-0571


  5 in total

1.  Follow-up with OM-8980 after a double-blind study of OM-8980 and auranofin in rheumatoid arthritis.

Authors:  T L Vischer
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

2.  A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.

Authors:  T L Vischer
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

3.  Functional and metabolic changes of guinea pig peritoneal macrophages induced by bacterial vaccines.

Authors:  J Takácová; D Kotulová; A Kasicková; M Ferencík
Journal:  Folia Microbiol (Praha)       Date:  1992       Impact factor: 2.099

4.  Double-blind, placebo-controlled study of OM-8980 in rheumatoid arthritis.

Authors:  J P Hauzeur; T Appelboom
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

5.  Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.

Authors:  P Conti; R A Dempsey; M Reale; R C Barbacane; M R Panara; M Bongrazio; J W Mier
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.